Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy
Chemotherapeutic drugs chronically administered to tumor-bearing mice, using a frequent schedule at doses substantially lower than the maximum tolerated dose (MTD) (i.e., metronomic dosing), can cause sustained and potent antiangiogenic effects by targeting the endothelial cells of newly growing tum...
Na minha lista:
| 發表在: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
National Academy of Sciences
2003
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC240719/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14561896/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.2135406100 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|